Top Markets
#1 Islamic Coin Islamic Coin +155.94%
#2 Siren Siren +37.70%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.25%
#4 Verus Coin Verus Coin +22.40%
#5 Cysic Cysic +19.60%
#6 OpenEden OpenEden +19.09%
#7 Ocean Protocol Ocean Protocol +14.70%
#8 Arowana Arowana +14.57%
#9 RedStone RedStone +13.95%
#10 Perle Perle +13.70%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Endymed Ltd Endymed Ltd

Endymed Ltd

ENDY
Rank in Stocks #31811
Endymed Ltd is a medical technology company focused on the global design,... Endymed Ltd is a medical technology company focused on the global design, development, and sale of energy-driven aesthetic treatment systems, catering to both professional practitioners and individual consumers. Its product offerings include the versatile EndyMed PRO, a platform capable of multiple applications. Another key product, PURE 2.0, provides professional-grade skin tightening, body contouring, and functional skin resurfacing. Furthermore, the firm leverages its proprietary 3DEEP radiofrequency technology to deliver a wide array of solutions for cosmetic enhancements, such as diminishing wrinkles, tightening skin, sculpting the body, improving texture, reducing cellulite and overall circumference, treating acne and related scarring, lessening stretch marks, performing RF microneedling, and fractional resurfacing. Established in 2007, the company is headquartered in Freehold, New Jersey.
Share Price
$0.90225185
Last synced: 2025-02-16
Market Cap
$11.99M
Change (1 day)
0.48%
Change (1 year)
0.00%
Country
US
Trade Endymed Ltd (ENDY)

Category

Healthcare
P/B ratio for Endymed Ltd (ENDY)
P/B ratio as of August 2026 TTM: 0.98
According to Endymed Ltd latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0.98. At the end of 2022 the company had a P/B ratio of 0.70.
P/B ratio history for Endymed Ltd from 2013 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
2026 (TTM) 0.98 27.27%
2023 0.77 9.21%
2022 0.70 -69.49%
2021 2.30 61.09%
2020 1.43 49.52%
2019 0.95 -5.86%
2018 1.01 -82.25%
2017 5.71 70.04%
2016 3.36 -22.26%
2015 4.32 62.06%
2014 2.67 -41.80%
2013 4.58 0.00%
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 3.7944 287.18%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 5.423 453.37%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 2.0146 105.57%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 3.072 213.47%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 4.9725 407.40%
US